盐酸羟考酮用于非体外循环冠状动脉旁路移植术后患者自控静脉镇痛的临床观察

摘要
图/表
参考文献(19)
相关文章 (1)

全文: PDF (588 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的观察盐酸羟考酮用于非体外循环冠状动脉旁路移植术（CABG）后镇痛的临床效果，以期优化镇痛泵配方。方法回顾性分析2015年10月~2016年4月中国医学科学院阜外医院100例非体外循环CABG患者的临床资料。根据术后镇痛泵配方，分为羟考酮组（O组）和舒芬太尼组（S组），各50例。O组的镇痛泵配方为羟考酮（0.8 mg/kg）和托烷司琼（5 mg），S组的镇痛泵配方为舒芬太尼（1.5 μg/kg）和托烷司琼（5 mg）。患者静脉自控镇痛（PCIA）自手术结束时开始。记录拔气管导管前30 min（T1）、拔管即刻（T2）、拔管后3 h（T3）、拔管后24 h（T4）的动脉收缩压（SBP）、舒张压（DBP）和心率（HR），T2~T4各时间点的疼痛和镇静评分、术后追加镇痛药、术后机械通气时长、重症监护室（ICU）停留时间、镇痛相关并发症等数据。结果 T2时间点，O组患者SBP和HR均高于S组，差异均有统计学意义（P < 0.05）。与T1时间点比较，T2时间点O组患者的SBP、DBP和HR与S组患者的SBP均明显升高，差异均有统计学意义（P < 0.05）。患者疼痛和镇静评分、术后追加镇痛药、术后机械通气时长、重症监护室停留时间和镇痛相关并发症的组间比较，差异均无统计学意义（P > 0.05）。结论盐酸羟考酮可安全、有效地用于非体外循环CABG患者的术后镇痛。两种不同配方镇痛泵（0.8 mg/kg羟考酮和1.5 μg/kg舒芬太尼）的临床镇痛效果无明显差别，麻醉医生应根据自身经验和患者情况进行选择。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	田丽娟石晟张喆▲ 陈雷▲

关键词 ：羟考酮, 非体外循环, 冠状动脉旁路移植术, 自控静脉镇痛

Abstract：Objective To observe the clinical effects of Oxycodone hydrochloride on postoperative analgesia after off-pump coronary artery bypass grafting (CABG) in order to optimize the prescription of analgesic pump. Methods Clinical data of off-pump CABG patients in Fuwai Hospital Chinese Academy of Medical Science from October 2015 to April 2016 were retrospectively analyzed. According to the prescription of postoperative analgesic pump, the patients were divided into Oxycodone group (group O) and Sufentanil group (group S) with 50 cases in each group. The analgesic pump in group O was composed of Oxycodone (0.8 mg/kg) and tropisetron (5 mg), and the analgesic pump formula in group S was Sufentanil (1.5 μg/kg) and tropisetron (5 mg). Patient controlled intravenous analgesia (PCIA) began at the end of surgery. The arterial systolic blood pressure (SBP), the arterial diastolic blood pressure (DBP) and the heart rate (HR) were collected at 30 min before extubation(T1), the moment of extubation(T2), 3 h after extubation (T3), and 24 h after extubation(T4)． Pain and sedative scores at each time points of T2 to T4, additional postoperative analgesics, length of postoperative mechanical ventilation, length of intensive care unit (ICU) stay and analgesic related complications were collected. Results At the time point of T2, the HR and SBP of group O were higher than those of group S, the differences were statistically significant (P < 0.05). At the time point of T2, the SBP, DBP, and HR of group O and the SBP of group S were increased significantly compared to the time point of T1 with statistical significance (P < 0.05). There was no significant difference between groups in pain and sedative score, additional postoperative analgesics, length of postoperative mechanical ventilation, length of intensive care unit (ICU) stay and analgesic related complications (P > 0.05). Conclusion Oxycodone hydrochloride is safe and effective for postoperative analgesia in patients undergoing off-pump CABG. There is no significant difference in the clinical analgesic effect between the two prescriptions (0.8 mg/kg Oxycodone and 1.5 μg/kg Sufentanil) of analgesia pumps, and the anesthesiologist should choose them according to their own experience and the patients′ condition.

Key words： Oxycodone Off-pump Coronary artery bypass grafting Controlled intravenous analgesia

通讯作者: ▲共同通讯作者

引用本文:

田丽娟石晟张喆▲ 陈雷▲. 盐酸羟考酮用于非体外循环冠状动脉旁路移植术后患者自控静脉镇痛的临床观察[J]. 中国医药导报, 2018, 15(25): 108-111.
TIAN Lijuan SHI Sheng ZHANG Zhe▲ CHEN Lei▲. Clinical observation of Oxycodone hydrochloride in patient-controlled intravenous analgesia after off-pump coronary artery bypass grafting. 中国医药导报, 2018, 15(25): 108-111.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I25/108

[1] 陈伟伟，高润霖，刘力生，等.《中国心血管病报告2016》概要[J].中国循环杂志，2017，32（6）：521-529.
[2] Sattari M，Baghdadchi ME，Kheyri M，et al. Study of patient pain management after heart surgery [J]. Adv Pharm Bull，2013，3（2）：373-377.
[3] Plicner D，Mazur P，Sadowski J，et al. Asymmetric dimethylarginine and oxidative stress following coronary artery bypass grafting： associations with postoperative outcome [J]. Eur J Cardiothorac Surg， 2014，45（5）：136-141.
[4] Lazzari M，Sabato AF，Caldarulo C，et al. Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain：an observational analysis [J]. Curr Med Res Opin，2014，30（4）：555-564.
[5] 徐建国.盐酸羟考酮的药理学和临床应用[J].临床麻醉学杂志，2014，5（30）：511-513.
[6] 中国心脏重症镇静镇痛专家委员会.中国心脏重症镇静镇痛专家共识[J].中华医学杂志，2017，97（10）：726-734.
[7] 王倩，冯艺.舒芬太尼的毒理作用及在心血管手术上的应用研究[J].毒理学杂志，2013，27（3）：222-223.
[8] 徐茜，李有长，胡佳.小剂量舒芬太尼在剖宫产术腰硬联合麻醉中预防寒颤及牵拉痛的临床观察[J].中国医药导报，2016，13（04）：85-88.
[9] 王月兰，邓小明，田玉科，等.成人手术后疼痛管理专家共识[J].临床麻醉学杂志，2017，33（8）：812-815.
[10] Yeon SL，Chong WB，Dong RK，et al. Comparison of hemodynamic response to tracheal intubation and postoperative pain in patients undergoing closed reduction of nasal bone fracture under general anesthesia： a randomized controlled trial comparing fentanyl and oxycodone [J]. BMC Anesthesiology，2016，16（1）：115.
[11] 朱文智，王东信.羟考酮在全身麻醉诱导中的临床应用[J].临床麻醉学杂志，2016，32（4）：341-343.
[12] 中国心胸血管麻醉学会，北京高血压防治协会.围术期高血压管理专家共识[J].临床麻醉学杂志，2016，3（32）：295-297.
[13] 许幸，吴新民，薛张纲，等.盐酸羟考酮注射液用于全麻患者术后镇痛的有效性和安全性：前瞻性、随机、盲法、多中心、阳性对照法临床研究[J].中华麻醉学杂志，2013，33（3）：269-274.
[14] 王美青，赵维珊，殷飞，等.羟考酮与地佐辛用于胸腔镜术后苏醒期镇痛的比较[J].中国医药导报，2016，13（25）：92-95.
[15] 杨亚杰，闫冰，刘立娟.盐酸羟考酮对妇科腹腔镜术后苏醒期患者的镇痛效果[J].中国医药导报，2016，13（13）：48-51，56.
[16] 张云霄，陈冀衡，范志毅，等.羟考酮与舒芬太尼用于胸腔镜肺癌根治术后病人静脉镇痛效果的比较[J].中华麻醉学杂志，2015，35（10）：1228-1230.
[17] 程旭丽，孙莹杰，林丹，等.羟考酮在非停跳冠状动脉旁路移植术术后镇痛中的应用[J].实用药物与临床，2018， 21（2）：161-163.
[18] Pasternak GW. Molecular biology of opioid analgesia [J]. J Pain Symptom Manage，2005，29（5 Suppl）：s2-s9.
[19] Konstantatos AH，Kavnoudias H，Stegeman JR，et al. A randomized，double-blind，placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids [J]. Cardiovasc Intervent Radiol，2014，37（5）：1191-1197.